Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meetings, 55853 [2021-21899]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 192 / Thursday, October 7, 2021 / Notices
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Ovarian Physiology.
Date: November 1, 2021.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6701 Rockledge Drive, Room 2131B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Luis E. Dettin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892, 301–827–8231,
luis.dettin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
Dated: October 4, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–21903 Filed 10–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meetings
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Population Sciences Study
Section.
Date: October 18, 2021.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
VerDate Sep<11>2014
17:46 Oct 06, 2021
Jkt 256001
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Christiane M. Robbins,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Rm. 2121B,
Bethesda, MD 20892, (301) 451–4989,
crobbins@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Archiving and
Documenting Child Health and Human
Development Data Sets.
Date: October 18, 2021.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Christiane M. Robbins,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2121B,
Bethesda, MD 20892, 301–451–4989,
crobbins@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children,
National Institutes of Health, HHS)
Dated: October 4, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–21899 Filed 10–6–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act. To request a
copy of these documents, call the
SAMHSA Reports Clearance Officer at
(240) 276–0361.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
55853
Project: State Opioid Response (SOR)/
Tribal Opioid Response (TOR) Program
Instrument (OMB No. 0930–0384)—
Revision
SAMHSA is requesting approval to
modify its existing CSAT SOR/TOR
Program Instrument by (1) collapsing
the original three questions into two
questions for clarity and (2) adding ten
questions in order to collect information
on Congressionally mandated and
programmatic activities, and comply
with reporting requirements. The
program-level information is collected
quarterly and entered and stored in
SAMHSA’s Performance Accountability
and Reporting System, which is a realtime, performance management system
that captures information on the
substance use prevention and treatment
and mental health services delivered in
the United States. Continued approval
of this information collection will allow
SAMHSA to continue to meet
Government Performance and Results
Modernization Act of 2010 reporting
requirements that quantify the effects
and accomplishments of its
discretionary grant programs.
The SOR/TOR programs were first
authorized under Title II Division H of
the Consolidated Appropriations Act,
2018, Public Law 115–141. SAMHSA
anticipates 159 recipients (states,
territories, and tribal entities) will
participate in these grant programs.
Grantee-level data will include
information related to: Reported
overdose reversals; the purchase and
distribution of naloxone; training in the
administration of naloxone;
implementation of prevention and
education activities; outreach activities
for underserved communities; and the
purchase and distribution of fentanyl
test strips. This grantee-level
information will be collected quarterly.
The revisions to the tool will enable
SAMHSA to better assess grantee
accountability and performance on the
required education and prevention
activities for the SOR/TOR programs.
SAMHSA will also use the data
collected through the revised tool to
implement recommendations resulting
from the GAO study, ‘‘Drug Misuse:
Agencies Have Not Fully Identified How
Grants That Can Support Drug
Prevention Education Programs
Contribute to National Goals (GAO–21–
96).1 Finally, the revisions will assist
SAMHSA in providing comprehensive
1 United States Government Accountability
Office. (2020, November). Drug Misuse: Agencies
Have Not Fully Identified How Grants That Can
Support Drug Prevention Education Programs
Contribute to National Goals. https://www.gao.gov/
assets/gao-21-96.pdf.
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 86, Number 192 (Thursday, October 7, 2021)]
[Notices]
[Page 55853]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21899]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health and
Human Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Initial Review Group; Population Sciences Study Section.
Date: October 18, 2021.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Eunice Kennedy Shriver National Institute of Child Health
and Human Development, National Institutes of Health, 6710B
Rockledge Drive, Room 2121B, Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Christiane M. Robbins, Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, National Institutes
of Health, 6710B Rockledge Drive, Rm. 2121B, Bethesda, MD 20892,
(301) 451-4989, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Archiving and Documenting Child
Health and Human Development Data Sets.
Date: October 18, 2021.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Eunice Kennedy Shriver National Institute of Child Health
and Human Development, National Institutes of Health, 6710B
Rockledge Drive, Room 2121B, Bethesda, MD 20892 (Video Assisted
Meeting).
Contact Person: Christiane M. Robbins, Scientific Review
Officer, Scientific Review Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, National Institutes
of Health, 6710B Rockledge Drive, Room 2121B, Bethesda, MD 20892,
301-451-4989, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children,
National Institutes of Health, HHS)
Dated: October 4, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-21899 Filed 10-6-21; 8:45 am]
BILLING CODE 4140-01-P
